✦ LIBER ✦

EKB-569, an irreversible inhibitor of the epidermal growth factor receptor: Phase 1 trial results in patients with advanced solid tumors

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I and pharmacokinetic study of dac

✍ Toshiaki Takahashi, Narikazu Boku, Haruyasu Murakami, Tateaki Naito, Asuka Tsuya 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 481 KB

Results of a phase I trial of the humani

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 139 KB

A phase I dose escalation study of epide

✍ Karp, D.D; Ferrante, K.J; Tensfeldt, T.G; Thurer, R.L; LoCicero, J; Huberman, M. 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 111 KB

A phase-I trial of the epidermal growth

✍ Matthew G. Fury; Allan Lipton; Katherine M. Smith; Corinne B. Winston; David G. 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 377 KB

552 Evaluation of the pharmacokinetic (P

✍ C. Delbaldo; J.Y. Pierga; V. Dieras; S. Faivre; M. Bonnay; J.C. Vedovato; M. Mue 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 164 KB

1462 POSTER A multicenter phase II trial

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 139 KB